ConductScience.org, home

Paper32289481

Oroxylin a promotes PGC-1α/Mfn2 signaling to attenuate hepatocyte pyroptosis via blocking mitochondrial ROS in alcoholic liver disease.

Kai J and 11 others. Free Radic Biol Med, 2020. Cited by 79 papers, by iCite.

Cite this record

ConductScience Library. Oroxylin a promotes PGC-1α/Mfn2 signaling to attenuate hepatocyte pyroptosis via blocking mitochondrial ROS in alcoholic liver disease. Papers, record 32289481. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32289481

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Oroxylin a promotes PGC-1α/Mfn2 signaling to attenuate hepatocyte pyroptosis via blocking mitochondrial ROS in alcoholic liver disease.
PubMed
Journal
Free Radic Biol Med
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
79
iCite
Relative citation ratio, by iCite
4.1
iCite
Revised in PubMed
2021-06-18
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kai JJun
2Yang XXiang
3Wang ZZhimin
4Wang FFeixia
5Jia YYan
6Wang SShijun
7Tan SShanzhong
8Chen AAnping
9Shao JJiangjuan
10Zhang FFeng
11Zhang ZZili
12Zheng SShizhong

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Liver Diseases, AlcoholicMajor topic
PyroptosisMajor topic
Animals
Flavonoids
GTP Phosphohydrolases
Hepatocytes
Male
Mice
Mice, Inbred ICR
Mitochondria
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
Reactive Oxygen Species

Source PubMed

Download CSV of topics

Cited by46

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 79 citations.

PMIDTitleJournalYearIn PapersSource
42908686
Clinical efficacy and multi-target mechanisms of liver-dispersing, bile-inducing, and heat-clearing TCM formulas in cholelithiasis: network meta-analysis, network pharmacology, and molecular docking study.
Front Med (Lausanne)2026https://conductscience.org/library/papers/42908686PubMed
42751505Flavonoids: biological activities, nutritional and immunological aspects, therapeutic potential, food applications, and human health benefits-A comprehensive review.Front Nutr2026https://conductscience.org/library/papers/42751505PubMed
42614562Immunometabolic pathways in liver fibrosis: current evidence for selected plant-derived metabolites associated with traditional Chinese medicine.Front Pharmacol2026https://conductscience.org/library/papers/42614562PubMed
42199808Natural Product Treatment for Metabolic Dysfunction-Associated Steatotic Liver Disease: Targeted Mitochondrial Quality Control.Drug Des Devel Ther2026https://conductscience.org/library/papers/42199808PubMed
42039261Oroxylin A ameliorates hepatic steatosis and non-alcoholic fatty liver disease through the regulation of CPT1A m6A methylation in hepatocytes.Biochem Biophys Rep2026https://conductscience.org/library/papers/42039261PubMed
41613015Bidirectional Regulation of NLRP3 Inflammasome and Mitochondrial Quality Control in Sepsis: Mechanisms and Therapeutic Implications.Mediators Inflamm2026https://conductscience.org/library/papers/41613015PubMed
41112736MRPL44 regulates lipid metabolism in metabolic dysfunction-associated steatotic liver disease through BNIP3-mediated mitophagy.Front Nutr2025https://conductscience.org/library/papers/41112736PubMed
40956539Calcium signalling and organelle crosstalk in cardiovascular disease: an interplay of cardiac cell death pathways.Mol Biol Rep2025https://conductscience.org/library/papers/40956539PubMed
40667485Therapeutic approaches for liver fibrosis/cirrhosis by targeting pyroptosis.Open Life Sci2025https://conductscience.org/library/papers/40667485PubMed
40102927Oroxylin A reverses SHP-2 oxidative inactivation in GPVI signaling to suppress platelet activation and thrombus formation.Thromb J2025https://conductscience.org/library/papers/40102927PubMed
39917567Dual role of pyroptosis in liver diseases: mechanisms, implications, and therapeutic perspectives.Front Cell Dev Biol2025https://conductscience.org/library/papers/39917567PubMed
39717669Exosomes from IH- Induced bEnd3 Cells Promote OSA Cognitive Impairment via miR-20a-5p/MFN2 Mediated Pyroptosis of HT22 Cells.Nat Sci Sleep2024https://conductscience.org/library/papers/39717669PubMed
39669199Alcohol-related liver disease (ALD): current perspectives on pathogenesis, therapeutic strategies, and animal models.Front Pharmacol2024https://conductscience.org/library/papers/39669199PubMed
39253100Natural Flavonoid-Derived Enzyme Mimics DHKNase Balance the Two-Edged Reactive Oxygen Species Function for Wound Healing and Inflammatory Bowel Disease Therapy.Research (Wash D C)2024https://conductscience.org/library/papers/39253100PubMed
39011036ROS induced pyroptosis in inflammatory disease and cancer.Front Immunol2024https://conductscience.org/library/papers/39011036PubMed
38863972Renal Tissue-Derived Exosomal miRNA-34a in Diabetic Nephropathy Induces Renal Tubular Cell Fibrosis by Promoting the Polarization of M1 Macrophages.IET Nanobiotechnol2024https://conductscience.org/library/papers/38863972PubMed
38666911Advances in Flavonoid Research: Sources, Biological Activities, and Developmental Prospectives.Curr Issues Mol Biol2024https://conductscience.org/library/papers/38666911PubMed
38621001Natural compounds may contribute in preventing SARS-CoV-2 infection: a narrative review.Food Sci Hum Wellness2022https://conductscience.org/library/papers/38621001PubMed
38343611Progress in the Correlation Between Inflammasome NLRP3 and Liver Fibrosis.J Clin Transl Hepatol2024https://conductscience.org/library/papers/38343611PubMed
38183609FXR overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in alcoholic liver disease.Hepatol Int2024https://conductscience.org/library/papers/38183609PubMed

See all 46 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
PPARGC1A10891PubTator's text mininghttps://conductscience.org/library/genes/10891

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32289481

GET https://conductscience.org/api/papers/v1/32289481/cited_by?page=2